Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid

BioTechGrid

  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
Posted inGenetics

Perseverance, Persistence Key to CAR T Success, Say Ross Prize Winners Carl June and Michel Sadelain

June 18, 2026
Continue Reading
perseverance,-persistence-key-to-car-t-success,-say-ross-prize-winners-carl-june-and-michel-sadelain
Posted inGenetics

Nirrin Technologies and S.T. Japan Partner on Next-Gen Protein Quantitation Tech

June 18, 2026
Continue Reading
nirrin-technologies-and-st.-japan-partner-on-next-gen-protein-quantitation-tech
Posted inBiotechnology

cAMPfield harvests $180M series A to advance oral IBD drug licensed from Newsoara

June 18, 2026
Continue Reading
campfield-harvests-$180m-series-a-to-advance-oral-ibd-drug-licensed-from-newsoara
Posted inBiotechnology

Kardigan buttons up $400M upsized IPO to power heart drugs toward phase 3

June 18, 2026
Continue Reading
kardigan-buttons-up-$400m-upsized-ipo-to-power-heart-drugs-toward-phase-3
Posted inMedical Technology

Novocure device fails to improve brain cancer patients’ survival in phase 3 test

June 18, 2026
Continue Reading
novocure-device-fails-to-improve-brain-cancer-patients’-survival-in-phase-3-test
Posted inBiotechnology

Biogen inks $1B RayThera buyout to bag preclinical immunology assets

June 18, 2026
Continue Reading
biogen-inks-$1b-raythera-buyout-to-bag-preclinical-immunology-assets
Most Popular Post
exploring-the-future-of-healthcare with-panos-karelis
Posted inArtificial intelligence

Exploring the Future of Healthcare with Panos Karelis

exploring-the-future-of-healthcare with-gordon-wishart,-check4cancer
Posted inArtificial intelligence

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

exploring-the-future-of-healthcare with-noam-shomron,-tel-aviv-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

exploring-the-future-of-healthcare with-raul-villamarin-rodriguez,-woxsen-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

perseverance,-persistence-key-to-car-t-success,-say-ross-prize-winners-carl-june-and-michel-sadelain
Posted inGenetics

Perseverance, Persistence Key to CAR T Success, Say Ross Prize Winners Carl June and Michel Sadelain

June 18, 2026
The two honorees, Michel Sadelain, PhD, and Carl June, MD, receive their awards during an event to celebrate the 13th…
Read More
nirrin-technologies-and-st.-japan-partner-on-next-gen-protein-quantitation-tech
Posted inGenetics

Nirrin Technologies and S.T. Japan Partner on Next-Gen Protein Quantitation Tech

June 18, 2026
Credit: Christoph Burgstedt/Science Photo Library/Getty Images Nirrin Technologies appointed S.T. Japan as its exclusive distribution partner for the TALOSTM protein…
Read More
campfield-harvests-$180m-series-a-to-advance-oral-ibd-drug-licensed-from-newsoara
Posted inBiotechnology

cAMPfield harvests $180M series A to advance oral IBD drug licensed from Newsoara

June 18, 2026
In another biotech born out of China’s “NewCo” model, cAMPfield Therapeutics has launched with a $180 million series A and…
Read More
kardigan-buttons-up-$400m-upsized-ipo-to-power-heart-drugs-toward-phase-3
Posted inBiotechnology

Kardigan buttons up $400M upsized IPO to power heart drugs toward phase 3

June 18, 2026
Kardigan’s IPO haul has come in 14% above expectations, grossing $400 million after the cardiovascular disease biotech upsized the offering and…
Read More
novocure-device-fails-to-improve-brain-cancer-patients’-survival-in-phase-3-test
Posted inMedical Technology

Novocure device fails to improve brain cancer patients’ survival in phase 3 test

June 18, 2026
Novocure’s tumor-treating electric fields device missed its primary endpoint in a late-stage glioblastoma trial.  The Swiss medtech’s product has an…
Read More
biogen-inks-$1b-raythera-buyout-to-bag-preclinical-immunology-assets
Posted inBiotechnology

Biogen inks $1B RayThera buyout to bag preclinical immunology assets

June 18, 2026
Biogen has struck a backloaded, $1 billion deal to buy RayThera, snagging a pipeline of anti-inflammatory drug candidates led by a…
Read More
confined-migration-causes-dna-damage-in-neurons
Posted inBiotechnology

Confined Migration Causes DNA Damage in Neurons

June 18, 2026
In a groundbreaking study published in Nature, researchers have illuminated the subtle yet profound effects of confined cellular migration on…
Read More
multimodal-multitask-ai-transforms-lung-cancer-grading
Posted inBiotechnology

Multimodal Multitask AI Transforms Lung Cancer Grading

June 18, 2026
In a groundbreaking advancement that could revolutionize cancer prognosis and treatment, a team of researchers led by Liu, X., Dai,…
Read More
new-study-seeks-to-prolong-immune-system-longevity
Posted inBiotechnology

New Study Seeks to Prolong Immune System Longevity

June 17, 2026
In a groundbreaking advance poised to transform the landscape of age-related immune decline, University College London (UCL) researchers are spearheading…
Read More
kaist-creates-next-generation-self-powered-wearable-sensor-withstanding-668%-stretch
Posted inBiotechnology

KAIST Creates Next-Generation Self-Powered Wearable Sensor withstanding 668% Stretch

June 17, 2026
In a groundbreaking advancement that promises to reshape the landscape of wearable technology and soft robotics, researchers at the Korea…
Read More

Posts pagination

1 2 3 … 1,989 Next page
You May Have Missed
novocure-device-fails-to-improve-brain-cancer-patients’-survival-in-phase-3-test
Posted inMedical Technology

Novocure device fails to improve brain cancer patients’ survival in phase 3 test

fda-clears-dexcom’s-stelo-otc-glucose-monitor-for-use-with-children
Posted inMedical Technology

FDA clears Dexcom’s Stelo OTC glucose monitor for use with children

irhythm-hit-by-cyberattack-that-compromised-patient-data,-says-operations-unaffected
Posted inMedical Technology

iRhythm hit by cyberattack that compromised patient data, says operations unaffected

amid-us-investment-tour,-j&j-makes-$1b-stop-in-florida-to-upgrade-contact-lens-plant
Posted inMedical Technology

Amid US investment tour, J&J makes $1B stop in Florida to upgrade contact lens plant

Privacy Policy    Terms

Scroll to Top